Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

RHB Bank, Q5A, Kampung Kenyalang Park, Kuching, Sarawak, Malaysia

Total all time reports:  1
Latest report: April 27, 2020 12:00 PM
RHB Bank confirms employee positive for Covid -19, RHB Bank, Q5A, Kampung Kenyalang Park, Kuching, Sarawak, Malaysia

RHB Bank confirms employee positive for Covid -19

April 27, 2020 12:00 PM

“An employee from RHB Bank at it's Simpang Tiga Branch in Kuching has tested positive for Covid-19. The affected employee was confirmed Covid-19 positive on April 25th and the branch has been closed since March 25th.

Source: malaymail.com See Less
Reported By SafelyHQ.com User

Related Reports

July 13, 2020 12:00 PM

“A Cooper Service employee in Texarkana tests positive for coronavirus

Source: texarkanagazette.com See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“Four staff members at Shooter's Pub recently tested positive for COVID-19. Any visitor between June 29 and July 6 was possibly exposed to the coronavirus.

Source: rivertowns.net See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Carrabba's Italian Grill, 2832 Washington Rd, Augusta, GA 30909, USA

Carrabba's Italian Grill, 2832 Washington Rd, Augusta, GA 30909, USA

July 13, 2020 12:00 PM

“An employee at Carrabba's Italian Grill on Washington Rd. in Augusta has tested positive for COVID-19. The employee felt fine before a shift at the time but learned of the positive result after.

So ... See Moreurce: wfxg.com See Less
Reported By SafelyHQ.com User

TSA agent test positive for Covid-19, O'Hare International Airport - Terminal 2 Departures, Chicago, IL 60666, USA

O'Hare International Airport - Terminal 2 Departures, Chicago, IL 60666, USA

July 13, 2020 12:00 PM

“A Transportation Security Administration worker at Terminal 2 in O’Hare International Airport has tested positive for COVID-19. The employee last worked Sunday morning.

Source: chicago.cbslocal.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Graceway IGA, 102 Leeward Hwy, Venetian Road Settlement TKCA 1ZZ, Turks and Caicos Islands

Graceway IGA, 102 Leeward Hwy, Venetian Road Settlement TKCA 1ZZ, Turks and Caicos Islands

July 13, 2020 12:00 PM

“An employee from Graceway IGA in Turks & Caicos has tested positive for COVID-19.

Source: gracewaysupermarkets.com See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“At least 70 employees at SFO have tested positive for COVID-19. It is unknown where the infected employees worked at the airport.

Source: sfoconnect.com See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“Three staff members at Broz Sports Bar & Grill recently tested positive for COVID-19. Anyone who visited the bar between June 25 and June 30 could have been exposed to the the coronavirus.

Source: rivertowns.net See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“I’m so terrified that my dad might have Covid-19. He’s exhibiting all of the symptoms and I’m starting to feel chest pain even though I’ve done nothing but stay inside and keep clean. THE PANDEMIC IS NOT OVER, STAY AT HOME, WEAR A MASK. THIS IS NOT A JOKE. See Less
Reported By SafelyHQ.com User

Six employees test positive for Covid-19, Chattanooga Area Regional Transportation Authority, 1617 Wilcox Blvd, Chattanooga, TN 37406, USA

Chattanooga Area Regional Transportation Authority, 1617 Wilcox Blvd, Chattanooga, TN 37406, USA

July 13, 2020 12:00 PM

“Six Chattanooga Area Regional Transportation Authority employees recently tested positive for COVID-19.

Source: wdef.com See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“A crew member at the Sonic in London tested positive for COVID-19 and Several crew members were told to self-quarantining.

Source: wymt.com See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

July 13, 2020 1:00 PM

“Company name: Ridley Block Operations
Brand name: Ultralyx
Product recalled: 12% Protein Sheep feed
Reason of the recall: Elevated levels of copper
FDA Recall date: July 13, 2020
Recall details: No other products are affected Ridley Block Operations is voluntarily recalling Ultralyx® 12% Protei ... See Moren Sheep with batch number HB01679401. The product has been found to contain elevated levels of copper. With prolonged consumption, the affected product could potentially have adverse health effects on sheep, including reductions in daily gains, icterus, partially cirrhotic livers and hemoglobin-stained kidneys. Occasionally, death occurs in copper-toxic sheep.

This recall relates only to Ultralyx 12% Protein Sheep with the following batch numbers printed on the package:

- Product Name: Ultralyx 12% Protein Sheep
- Batch/Lot# : HB01679401
- Item No./Product No.: 24419
- Package Info.: 50# Block

Customers are asked to remove all product matching this batch number from distribution and inventory and discontinue feeding it immediately.

No other batch number or other Ridley Block Operations products are involved in this voluntary recall. Of the batch of twenty blocks included in the recall, two blocks remain in the marketplace.

Ridley Block Operations will continue to work closely with the Food and Drug Administration throughout the recall process. Our representatives are in direct communication with our customers to ensure the proper identification and removal of the impacted products.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

June 1, 2020 6:00 PM

“Company name: Amneal Pharmaceuticals LLC
Brand name: Amneal
Product recalled: Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg
Reason of the recall: Due to detection of N-Nitrosodimethylamine (NDMA)
FDA Recall date: June 01, 2020
Recall details: Amneal Pharmaceuticals L ... See MoreLC Bridgewater, New Jersey (Amneal), is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, within expiry to the Retail Level. Amneal was notified by the U.S. FDA that the Agency’s testing of seven lots of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, showed N-Nitrosodimethylamine (NDMA) amounts above acceptable FDA levels.

FDA recommended the recall of the seven tested lots. Amneal has agreed to this recall and has further decided to extend the recall to all lots within expiry of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, out of an abundance of caution. Further scientific evaluations are ongoing at Amneal. To date, Amneal has not received any reports of adverse events that have been confirmed to be directly related to this recall. Amneal’s Metformin Hydrochloride Immediate Release Tablets, USP are not affected by this recall.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant found in water and foods, including meats, dairy products, and vegetables. Metformin HCl Extended-Release Tablets, USP, 500 mg and 750 mg, manufactured by Amneal, are prescription, solid oral products that are indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. The Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, subject to the recall, are identified by the NDC numbers stated on the product label.

Metformin HCl Extended-Release Tablets, USP, 500 mg
53746-178-01. 100 count bottles
53746-178-05. 500 count bottles
53746-178-10. 1000 count bottles
53746-178-90. 90 count bottles
53746-178-Bulk. Bulk Box
65162-178-09. 90 count bottles
65162-178-10. 100 count bottles
65162-178-11. 1000 count bottles
65162-178-50. 500 count bottles

Metformin HCl Extended-Release Tablets, USP, 750 mg
53746-179-01. 1000 count bottles
53746-179-Bulk. Bulk Box
65162-179-10. 100 count bottles

The affected Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, lots were distributed nationwide in the US directly to Wholesalers, Distributors, Retailers, and Repackagers.

Amneal is notifying its direct customers via mail (UPS Standard Overnight) by mailing a recall notification letter and is arranging for the return of all the recalled products. Anyone with an existing inventory of the product should quarantine the recalled lots immediately.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

April 20, 2020 4:00 PM

“Company name: Fresenius Kabi USA, LLC
Brand name: Fresenius Kabi
Product recalled: Ketorolac Tromethamine Injection, USP, 30 mg/mL, and Ketorolac Tromethamine Injection, USP, 60 mg/2 mL
Reason of the recall: Presence of Particulate Matter
FDA Recall date: April 20, 2020
Recall details: Freseni ... See Moreus Kabi USA, LLC is voluntarily recalling 13 lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial and Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL fill in a 2 mL amber vial to the user level due to the presence of particulate matter composed of the following elements: carbon, silicon, oxygen, and polyamides.

Particulate matter was found in eight reserve sample vials. Administration of products containing particulate matter could obstruct blood vessels and result in local irritation of blood vessels, swelling at the site of injection, a mass of tissue that could become inflamed and infected, blood clots traveling to the lung, scarring of the lung tissues, and allergic reactions that could lead to life-threatening consequences.

Ketorolac Tromethamine, a nonsteroidal anti-inflammatory drug, is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level. The total combined duration of use of oral Ketorolac Tromethamine and Ketorolac Tromethamine injection should not exceed 5 days. Listed below is a table of the recalled lots distributed nationwide to wholesalers, distributors, hospitals, and pharmacies between May 5, 2018 and December 16, 2019, as well as a copy of the label:

- Ketorolac Tromethamine Injection, USP, 30 mg / mL, 1 mL fill in a 2 mL amber vial. NDC: 63323-162-01. Product code: 160201. (Check the recall notice for specific batch numbers)
- Ketorolac Tromethamine Injection, USP, 60 mg / 2 mL (30 mg / mL), 2 mL fill in a 2 mL amber vial. NDC: 63323-162-02. Product code: 160202. (Check the recall notice for specific batch numbers)

Check the full recalled product list and details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

June 3, 2020 3:34 PM

“Shoutout them for giving me raw chicken nuggets tonight. See Less
Reported By SafelyHQ.com User

July 6, 2020 3:00 PM

“Company name: ITECH 361
Brand name: All Clean
Product recalled: Hand sanitizer
Reason of the recall: Potential presence of methanol (wood alcohol).
FDA Recall date: July 06, 2020
Recall details: Company Announcement ITECH 361 is voluntarily recalling 18,940 bottles of All Clean Hand Sanitizer, ... See MoreMoisturizer and Disinfectant sold in one liter bottles to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol). Risk Statement: Substantial methanol exposure can result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system or death. Although all persons using these products on their hands are at risk, young children who accidently ingest these products and adolescents and adults who drink these products as an alcohol (ethanol) substitute, are most at risk for methanol poisoning To date ITECH 361 has not received reports of adverse events related to this recall. The product is used as a hand sanitizer and moisturizer and is packaged in one (1) liter plastic bottles with UPC Code 628055370130. All Clean Hand Sanitizer and Moisturizer was distributed Nationwide to wholesale distributors and retailers. ITECH 361 is notifying its distributors by a Notice of a voluntary recall and consumers via this press release. ITECH 361 is arranging for return/replacement or refund of all recalled products. Consumers/distributors/retailers that have the product subject to this recall should stop using All Clean Hand Sanitizer, Moisturizer and Disinfectant and return it to the place of purchase. Consumers with questions regarding this recall can contact Corina Enriquez by phone number (888)405-4442 or e-mail at corina@itech361.com, Monday through Friday beginning July 6, 9:00a.m. to 5:00 p.m. (MDT). Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User

May 22, 2020 4:00 PM

“Company name: Acella Pharmaceuticals, LLC
Brand name: Acella
Product recalled: 30-mg, 60-mg and 90-mg NP Thyroid®
Reason of the recall: Super potency
FDA Recall date: May 22, 2020
Recall details: Company Announcement Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30 ... See More-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive superpotent NP Thyroid, may experience signs and symptoms of hyperthyroidism (overactive thyroid) which include, but are not limited to, weight loss, heat intolerance, fatigue, muscle weakness, hypertension, chest pain, rapid heart rate, or heart rhythm disturbances. Pregnant women who take superpotent NP Thyroid may also experience negative maternal and fetal outcomes including miscarriage and/or impairment to fetal development. Patients should talk to their healthcare professional before they stop taking their NP Thyroid medicine. To date, Acella has received two reports of adverse events known to be related to this recall. NP Thyroid (thyroid tablets, USP) is composed of levothyroxine and liothyronine, and used to treat hypothyroidism (underactive thyroid). The products subject to recall are packed in 100-count bottles. See product images. To best identify the product, the NDC’s, Product Description, Lot Numbers and Expiration Dates are listed. These lots were distributed nationwide in the USA to Acella’s direct accounts.
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User

March 17, 2020 8:43 PM

“Interview - Maroy, Lyon France:
This is a first hand account of the coronavirus situation in Lyon France, including one member of their community that has been diagnosed, and another working in a nearby hospital.

Maroy:
I am 25 and I'm living in Lyon in the east France and it's like the third ... See Moreregion which is the most touched by the virus. And right now I'm at home since Monday the government told us to stay at home, so I'm not touched by the virus, but I know some, an old person who are touched by the virus. And I have a friend who is working in the hospital in the care units and she explained to me what the media is hiding and what's the truth behind this virus.

Safelyhq:
What area does your friend work in the hospital? And what is she seeing?

Maroy:
She's living in the South of France, Toulouse and she's in the care units. So she's working closely with the people who are in the worst situation in the hospital. So she see's a lot of cases everyday and everyday she's told me that it's worse.

Safelyhq:
Some of the materials state that it's mostly older people that are impacted, is that what she's seeing?

Maroy:
So at first in the media, they say that only old people and fragile persons who have a disease are impacted. But now this is not the truth. Now,people who are 23 years old, 25, 30 are impacted.

Safelyhq:
Have you heard anything about testing? Is it hard to get testing or is it easy to get testing?

Maroy:
Yes. One week ago I was talking with my doctor and we were talking about the virus and he told me, you know, we are talking a lot with the other doctors and I can tell you right now that we don't have in France,no testing, no tests anymore. We don't know if a person has a flu, if it's simple flu or the coronavirus and when he told me that I was really anxious because even the doctors can't diagnose now if this only a flu or if it's worse.

Safelyhq:
At the hospital, where your friend works? Is there enough room for people or are they worried about how much space they have?

Maroy:
No, unfortunately not. Now they are transferring patients to another hospital to welcome the patients who are infected by the virus. And I also heard that in some hospitals they are taking the children's room. So the services reserved for children, they are transferred to the care unit because they do not have enough room for them. They don't have enough places now.

Safelyhq:
Is there anyone that you know of or any people that you are aware ofthat directly, or through friends or family that have been diagnosed with coronavirus?

Maroy:
Yes, the cousin of my husband has been diagnosed so she's at home. She can't be at the hospital because there are too many people and they said that if she don't have struggle to breathe, she needs to stay at home. The government said that you can call emergency, only if you're struggling to breathe, if you should just have fever. Or a cough if you cough you stay at home, but really if you can't breathe you can call the emergency.

Safelyhq:
So now that you've had experience in France with coronavirus, and hearing about your husband's cousin and your friend at the hospital, what's your feeling about coronavirus and how serious it is? Are you concerned now that you have had direct impact?

Maroy:
Yes. I'm really mad get the government because they they take that too easily. They didn't do the right things at the beginning. People need to understand that this is really, really serious. And I'm pretty anxious because now yesterday I was doing shopping, so just to buy food and the all people in the grocery was afraid was wearing masks and there was nothing, people were struggling to find some pasta or something like that. And I'm really mad because we can see that a lot and a lot of people are infected by the virus. My friend who is nurse, is really afraid, she's really anxious, she's really scared to have it. She's pregnant and she needs to work even if she's pregnant. And I'm really mad against the government for that. I'm sure that if it took the good decision at the right time, they would not have a lot of cases like right now.

Safelyhq:
Is there any message that you have for people listening based on what you've learnt so far?

Maroy:
Don't take that too lightly. This is really my word, don't take that too lightly. When I see that in UK, they say that they are counting on the auto immunity of people. I just don't understand. If I have a thing to say it, don't shake hands, don't hug someone, wash your hands carefully, and just take it this really, really seriously. Because this is not a simple flu. It's bigger than that.
See Less
Reported By SafelyHQ.com User

June 21, 2020 11:30 AM

“why am I being given raw chicken? See Less
Reported By SafelyHQ.com User

June 27, 2020 10:00 AM

“Company name: Saniderm Products
Brand name: Saniderm
Product recalled: Advanced Hand Sanitizer
Reason of the recall: May contain methanol (wood alcohol)
FDA Recall date: June 27, 2020
Recall details: Saniderm Products (Saniderm) is voluntarily recalling Saniderm Advanced Hand Sanitizer, packag ... See Moreed in 1-liter bottles to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol). To date, Saniderm has not received any reports of adverse events related to the product in question.

In response to a recent news alert by the Food and Drug Administration advising consumers of potentially toxic hand sanitizer manufactured by Eskbiochem SA de CV in Mexico, Saniderm has proactively taken necessary precautions to ensure the safety of consumers. Out of an abundance of caution, Saniderm has initiated a voluntary recall of all products produced by Eskbiochem SA de CV with a “Made in Mexico” origin.

The product is a hand sanitizer and is packaged in 1-liter plastic bottles with an orange twist-top cap. The affected Sandiderm Advanced Hand Sanitizer include lot number 53131626, manufactured date April/1/20, clear bottle that can be further distinguished by looking at the back side label and identifying “Made in Mexico” and “Produced by: Eskbiochem SA de CV”. No other bottles distributed by Saniderm match the description above, hence all products as described above are subject to the voluntary recall. The product can be identified by the photos below. The product was distributed in Virginia, Maryland, and New Jersey on April 15,2020.

Risk Statement: Substantial methanol exposure “could result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system or death. Although all persons using these products on their hands are at risk, young children who accidentally ingest these products and adolescents and adults who drink these products as an alcohol (ethanol) substitute, are most at risk for methanol poisoning.”

Saniderm is notifying its distributors and customers by email and is arranging for the handling of all voluntary recalled products. All individuals that have the bottle in question should immediately stop using and contact Saniderm for guidance on the return and disposal of the product. Consumers with questions regarding this voluntary recall can contact Saniderm at +1 (415) 562-5502‬ or info@sanidermproducts.com from Monday-Friday 9am-6pm, PST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

June 11, 2020 1:00 PM

“Company name: Lupin Pharmaceuticals, Inc
Brand name: Lupin
Product recalled: Metformin Hydrochloride Extended-release Tablets
Reason of the recall: Detection of N-Nitrosodimethylamine (NDMA)
FDA Recall date: June 11, 2020
Recall details: Lupin Pharmaceuticals Inc. is voluntarily recalling Met ... See Moreformin Hydrochloride Extended-Release Tablets USP (generic equivalent of Fortamet®), 500mg, lot G901203 to the consumer level. FDA analysis revealed that this lot exceeded the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA). To date, Lupin Pharmaceuticals Inc. has not received any reports of adverse events related to this recall.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products and vegetables. Metformin Hydrochloride Extended-Release Tablets USP, 500mg is a prescription oral medication indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. It is packaged in a bottle containing 60 tablets with NDC 68180-336-07. The affected lot of Metformin Hydrochloride Extended-Release Tablets USP, 500mg is included in below table:

- Product Name: Metformin Hydrochloride Extended-Release Tablets USP, 500mg

- NDC: 68180-336-07

- Lot Number: G901203

- Expiration Date: 12/2020

The product can be identified by the NDC and the lot number available on the side of the bottle label. Metformin Hydrochloride Extended-Release Tablets USP, 500mg was distributed nationwide in the USA to wholesalers, distributors, and mail order pharmacies.

Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, and mail order pharmacies by phone and through recall notification and is arranging for the return of all the recalled product lot. Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. According to the U.S. Food & Drug Administration, it could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professionals.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User